CERTOLIZUMAB PEGOL PERSISTENCE AND ADHERENCE BY DRUG FORMULATION, IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, OR RHEUMATOID ARTHRITIS

被引：0
|
作者：
Beaty, S. [1 ]
Zichlin, M. L. [2 ]
Hopson, S. [1 ]
Devine, F. [2 ]
Pi, S. [2 ]
Moore, J. [3 ]
Swallow, E. [2 ]
机构：
[1] UCB Pharma, Smyrna, GA USA
[2] Anal Grp Inc, Boston, MA USA
[3] Mercer Univ, Coll Pharm, Atlanta, GA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR106
引用
收藏
页码：S561 / S561
页数：1
相关论文
共 50 条
  • [31] Certolizumab pegol in rheumatoid arthritis: current update
    Fechtenbaum, Marie
    Yusof, Md Yuzaiful Md
    Emery, Paul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (06) : 841 - 850
  • [32] CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS: THE CANNOCK EXPERIENCE
    Roskell, Samantha
    Toms, Tracey
    Raghuvanshi, Subhra
    Price, Arthur
    Passey, Kathleen
    Sheeran, Thomas
    Venkatachalam, Srinivasan
    RHEUMATOLOGY, 2014, 53 : 111 - 111
  • [33] Characteristics of Patients with Seropositive or Seronegative Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from the US-Based Corrona Rheumatoid Arthritis and Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registries
    Ogdie, Alexis
    Liu, Mei
    Rebello, Sabrina
    Cronin, Angel
    Dube, Blessing
    McLean, Robert
    Yi, Esther
    Hur, Peter
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [34] MEDICATION ADHERENCE IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS
    Barbosa, L.
    Cordeiro, I.
    Cordeiro, A.
    Santos, M. J.
    da Silva, J. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 105 - 105
  • [35] CERTOLIZUMAB PEGOL IN A SPANISH COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS - PRELIMINARY RESULTS
    Reina, D.
    Mateo, L.
    Prior, A.
    Laiz, A.
    Moreno, M.
    Juanola, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 722 - 722
  • [36] Certolizumab Pegol (Cimzia) and Ustekinumab (Stelara) for Psoriatic Arthritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1435): : 10 - 12
  • [37] Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
    Connock, M.
    Tubeuf, S.
    Malottki, K.
    Uthman, A.
    Round, J.
    Bayliss, S.
    Meads, C.
    Moore, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 1 - 10
  • [38] Effectiveness of Certolizumab Pegol in the Treatment of Psoriasis in a Cohort of Patients With Psoriatic Arthritis
    Reina, D.
    Vidal, D.
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (08): : 703 - 704
  • [39] Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis
    Carron, Philippe
    Lambert, Bieke
    Van Praet, Liesbet
    De Vos, Filip
    Varkas, Gaelle
    Jans, Lennart
    Elewaut, Dirk
    Van den Bosch, Filip
    RMD OPEN, 2016, 2 (01):
  • [40] Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
    van der Heijde, D.
    Deodhar, A.
    Fleischmann, R.
    Mease, P. J.
    Rudwaleit, M.
    Nurminen, T.
    Davies, O.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (07) : 1030 - 1039
12345